Biocept Inc logo

BIOC - Biocept Inc News Story

$4.43 0.2  3.5%

Last Trade - 14/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £42.1m
Enterprise Value £34.2m
Revenue £31.1m
Position in Universe 5513th / 6846

BRIEF-Biocept Q4 Loss Per Share $1.43

Thu 28th March, 2019 8:25pm
March 28 (Reuters) - Biocept Inc  BIOC.O :
    * BIOCEPT REPORTS 2018 FOURTH QUARTER AND FULL YEAR
FINANCIAL
RESULTS
    * Q4 LOSS PER SHARE $1.43
    * Q4 EARNINGS PER SHARE ESTIMATE $-1.41 -- REFINITIV IBES
DATA
    * Q4 REVENUE $860,000 VERSUS REFINITIV IBES ESTIMATE OF
$912,000
    * CASH AND CASH EQUIVALENTS WERE $3.4 MILLION AS OF DECEMBER
31,
2018, COMPARED WITH $2.1 MILLION AS OF DECEMBER 31, 2017

Source text for Eikon:  ID:nPn8g9fzma 
Further company coverage:  BIOC.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.